US WorldMeds, LLC

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Sloan Pharma S.a.r.l
  • Solstice Neurosciences
See more in Biomedtracker

Latest on US WorldMeds, LLC

Pink Sheet

US FDA ‘Thinking Deeply’ On ‘Digital Twins’ As Placebo Control, But OCE Not Quite Ready To Embrace It

 
• By Kate Rawson

The Oncology Center of Excellence says it is open to considering the use of artificial intelligence-powered “digital twins” as an alternative to human placebos in clinical trials, but OCE is not quite

Pink Sheet

Confirmatory Evidence: FDA Guidance Allowance For Use Of Animal Data Draws Split Views

 
• By Sue Sutter

The US Food and Drug Administration’s draft guidance on demonstrating substantial evidence of efficacy has drawn split views on the suitability of animal data to serve as confirmatory evidence, while

Pink Sheet

Real-Time Oncology Review Speeds Supplements At US FDA, But Gives Modest Benefit For Novel Agents

 
• By Bridget Silverman

The US FDA’s latest approvals under the popular Real-Time Oncology Review (RTOR) program present extreme examples of the pilot initiative’s effect on review times, from the astonishingly quick (a Keyt

Pink Sheet

Breakthrough Bounceback Looks Unlikely At US FDA’s CDER, But CBER Is Riding Wave Of RMATs

 
• By Bridget Silverman

The US FDA’s marquee expedited review program, the breakthrough therapy designation, is likely to see less of an impact on novel approvals in 2023 than in past years, a Pink Sheet analysis indicates.